.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster Self-Study
P017

2-Desaza Annomontine (C81) Impedes Angiogenesis Through Inhibition of CDC2-like Kinases (CLKs) and β-Catenin Activity

Appointment

Date: 13/03/2024

Time: 17:00 – 17:00

Talk time: 0 Min.

Discussion time: 0 Min.

Location / Stream:

Poster Self-Study 2

Session

Cancer pharmacology

Topic

Cancer pharmacology

Authors

Thomas Zech (Frankfurt am Main / DE), Mandy Hector (Cologne / DE), Anne Wolf (Cologne / DE), Lena Berger (Frankfurt am Main / DE), Susanne Müller (Frankfurt am Main / DE), Iris Bischoff-Kont (Frankfurt am Main / DE), Güzin Melissa Krishnathas (Frankfurt am Main / DE), Silvia Kuntschar (Frankfurt am Main / DE), Tobias Schmid (Frankfurt am Main / DE), Franz Bracher (Munich / DE), Stefan Knapp (Frankfurt am Main / DE), Thomas Langmann (Cologne / DE), Robert Fürst (Munich / DE)